HIGHLIGHTS
- who: Heran Deng from the This study was a multicenter, retrospective, real-world study (RWS) that included early TNBC patients treated with neoadjuvant immunotherapy between November , and December , across , institutions, including Sun Yat-sen Memorial Hospital, Xiangya Hospital of Central South University, Sun Yat-sen University Cancer Center, the Second Xiangya Hospital of Central South University, the Southwest Hospital of AMU, Union Hospital Tongji Medical College Huazhong University have published the article: Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data, in the Journal: (JOURNAL . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.